Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer

Approximately 30% of breast cancer (BC) patients suffer from disease relapse after definitive treatment. Monitoring BC at baseline and disease progression using comprehensive genomic profiling would facilitate the prediction of prognosis. We retrospectively studied 101 BC patients ultimately experie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lanxin, Sun, Siwen, Zhao, Xiaotian, Liu, Jingwen, Xu, Yang, Xu, Lingzhi, Song, Chen, Li, Na, Yu, Jing, Zhao, Shanshan, Yu, Peiyao, Fang, Fengqi, Xie, Jiping, Ji, Xuening, Yu, Ruoying, Ou, Qiuxiang, Zhao, Zuowei, Li, Man
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580879/
https://www.ncbi.nlm.nih.gov/pubmed/35971249
http://dx.doi.org/10.1002/1878-0261.13297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580879/
https://www.ncbi.nlm.nih.gov/pubmed/35971249
http://dx.doi.org/10.1002/1878-0261.13297

Ejemplares similares